Overview
- The University of Bath secured £500,000 from the EPSRC Health Technologies Connectivity Awards to develop the GlucoBrain device.
- The chip will connect living human models of the gut, pancreas, and brain through tiny fluid channels to track glucose and hormone signals linked to memory loss.
- The three-year pilot begins in October, starting with separate organ modules that will then be joined into one connected system.
- Oxford researchers will guide diabetes and metabolic disease modeling, while Johns Hopkins brings Alzheimer’s and brain organoid expertise.
- The team aims to speed drug testing, reduce animal use, and move toward personalized treatment screening using patient cells, with AI analysis planned for pattern-finding.